Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Posttransplantation lymphoproliferative disorders.

Pietro Andreone1, Annagiulia Gramenzi, Stefania Lorenzini

  • 1Dipartimento di Medicina Interna, CardioAngiologia ed Epatologia, Policlinico S Orsola-Malpighi, Bologna, Italy. andreone@med.unibo.it

Archives of Internal Medicine
|September 25, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of human albumin infusion on inflammation, oxidative stress, and prognosis in decompensated cirrhosis: a prospective cohort study with a meta-analysis.

BMC gastroenterology·2026
Same author

High-dosage human albumin infusion may be superior for hypervolemic hyponatremia in cirrhosis with ascites.

Expert review of gastroenterology & hepatology·2025
Same author

Human Albumin infusion in liver Cirrhosis and overt Hepatic Encephalopathy (HACHE): protocol of an investigator-initiated, open-label, multicentre, randomised controlled trial.

BMJ open·2025
Same author

Correction: Guarneri et al. Diagnostic Performance of PIVKA-II in Italian Patients with Hepatocellular Carcinoma. <i>Cancers</i> 2025, <i>17</i>, 167.

Cancers·2025
Same author

Diagnostic Performance of PIVKA-II in Italian Patients with Hepatocellular Carcinoma.

Cancers·2025
Same author

Itching for Answers: A Comprehensive Review of Cholestatic Pruritus Treatments.

Biomolecules·2024

Posttransplantation lymphoproliferative disorders (PTLD) are common, Epstein-Barr virus-associated B-cell diseases often seen after organ transplants. PTLD has a poor prognosis, necessitating updated clinical knowledge for effective management.

Area of Science:

  • Oncology
  • Virology
  • Immunology

Background:

  • Posttransplantation lymphoproliferative disorders (PTLD) encompass a range of B-cell diseases, frequently linked to Epstein-Barr virus (EBV).
  • These conditions arise due to intense immunosuppression following organ transplantation, with increasing incidence.
  • PTLD often presents with a poor prognosis, despite therapeutic interventions.

Purpose of the Study:

  • To review current knowledge on the clinical features, diagnosis, prophylaxis, and treatment of PTLD.
  • To provide healthcare professionals with updated information for managing these life-threatening posttransplantation complications.

Main Methods:

  • Literature review of recent studies on PTLD.
  • Synthesis of clinical data, diagnostic criteria, and therapeutic strategies.

Related Experiment Videos

Main Results:

  • PTLD is predominantly an EBV-associated B-cell lymphoproliferative disorder.
  • Increased organ transplantation and immunosuppression correlate with rising PTLD rates.
  • Effective management strategies are crucial due to the often-poor patient outcomes.

Conclusions:

  • PTLD represents a significant clinical challenge in posttransplantation care.
  • A comprehensive understanding of PTLD's clinical aspects, diagnosis, and treatment is vital.
  • Continued research and updated clinical guidelines are essential for improving PTLD patient survival.